Patents Assigned to SHENZHEN ZHONGKE AMSHENN PHARMACEUTICAL CO., LTD.
  • Human sDR5-fc recombinant fusion protein and application thereof
    Patent number: 11220533
    Abstract: An sDR5-Fc recombinant fusion protein having amino acid sequence of SEQ ID NO: 2 and a gene encoding the protein and having a nucleotide sequence as shown in SEQ ID NO: 1 are provided. Further, applications of the protein and the gene in the preparation of medicament for preventing and treating autoimmune hepatitis or drug-induced liver injury are provided.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: January 11, 2022
    Assignee: SHENZHEN ZHONGKE AMSHENN PHARMACEUTICAL CO., LTD.
    Inventors: Xiaochun Wan, Junxin Li, Qian Chen, Qingmei Zhang
  • Human sDR5-Fc Recombinant Fusion Protein and Application Thereof
    Publication number: 20190352354
    Abstract: An sDR5-Fc recombinant fusion protein having amino acid sequence of SEQ ID NO: 2 and a gene encoding the protein and having a nucleotide sequence as shown in SEQ ID NO: 1 are provided. Further, applications of the protein and the gene in the preparation of medicament for preventing and treating autoimmune hepatitis or drug-induced liver injury are provided.
    Type: Application
    Filed: July 11, 2016
    Publication date: November 21, 2019
    Applicant: SHENZHEN ZHONGKE AMSHENN PHARMACEUTICAL CO., LTD.
    Inventors: Xiaochun WAN, Junxin LI, Qian CHEN, Qingmei ZHANG